136 related articles for article (PubMed ID: 32855746)
21. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
22. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
[TBL] [Abstract][Full Text] [Related]
23. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer.
Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
J Magn Reson Imaging; 2017 Jun; 45(6):1771-1779. PubMed ID: 27859961
[TBL] [Abstract][Full Text] [Related]
24. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
[TBL] [Abstract][Full Text] [Related]
25. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
26. Expression of immune cell markers and tumor markers in patients with cervical cancer.
Zhang L; Zhang H; Huang Y; Xi X; Sun Y
Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
29. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
Qin R; Cao L; Wang J; Liu J
Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
31. Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2.
Zhou Y; Wang W; Wei R; Jiang G; Li F; Chen X; Wang X; Long S; Ma D; Xi L
Int J Oncol; 2019 Jul; 55(1):131-141. PubMed ID: 31059006
[TBL] [Abstract][Full Text] [Related]
32. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
33. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M
Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690
[TBL] [Abstract][Full Text] [Related]
34. Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.
Dong A; Xu B; Wang Z; Miao X
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014679
[TBL] [Abstract][Full Text] [Related]
35. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
37. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
38. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
39. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
40. WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4.
Taniuchi K; Furihata M; Naganuma S; Saibara T
Cancer Med; 2018 Nov; 7(11):5733-5751. PubMed ID: 30353690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
